HOME >> BIOLOGY >> NEWS
Wildfire suppression costs may be reduced using new model

Portland, Ore. June 28, 2006. Recent research shows that using the right mix of agency and contract crews is the most cost effective way to fight fires rather than using contract or agency crews exclusively, according to Geoffrey Donovan, a research forester at the Forest Service's Pacific Northwest Research Station.

Donovan arrived at these findings after analyzing the full cost of 33 Forest Service type II fire crews dispatched during the 2003 fire season from five national forests in Oregon and Washington. The costs were estimated and compared with the cost of contract crews dispatched in the same region.

"My model helps managers to reduce costs by finding the optimal mix of contract and agency crews," explains Donovan. "A comparison of the full cost of a contract and an agency crew shows that if an agency crew is provided with continuous work, then the cost of that crew is approximately 70 percent of the cost of a contract crew. However, if an agency crew is not provided with continuous work, then it quickly loses its cost advantage."

The model so far, is applicable only to Oregon and Washington, although the methodology can be applied in other areas of the country. The entire study appears in the Western Journal of Applied Forestry and in the research publication, Ecological Modeling.

Wildfire suppression costs in the West and across the country have increased dramatically in the past 10 years. Public land managers are struggling with shrinking budgets, rising costs for personnel and equipment, and higher demand for services from rural communities. As a result, the Forest Service is increasingly relying on contract fire crews and using fewer agency fire crews.


'"/>

Contact: Sherri Richardson Dodge
srichardsondodge@fs.fed.us
503-808-2137
USDA Forest Service, Pacific Northwest Research Station
28-Jun-2006


Page: 1

Related biology news :

1. Wildfires and home prices: Are they related?
2. Natural mechanism for immune suppression paves way for cancer trials
3. Oxidative stress stimulates p38 MAPK-mediated tumor suppression
4. Scripps Research study reveals new function of protein kinase pathway in tumor suppression
5. Transplant cures rats type 2 diabetes without need for immune suppression drugs
6. UCSF study shows suppression of telomerase enzyme can inhibit spread of melanoma
7. p53, tumor suppression and aging
8. Researchers find a potential key to human immune suppression in space
9. Researchers find BRCA1 tumor suppression nullified by cyclin D1
10. BRCA1 tumor suppression nullified by cyclin D1 at the estrogen receptor
11. Gene changes linked to deficient immune suppression in MS

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Wildfire suppression costs may reduced using new model

(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions ... the entire spectrum of clinical research, is proud to ... the company,s comprehensive SaaS-based eClinical technology platform, has led ... the first two quarters of 2015.   Q2 2015 ... largest quarters measured by contract value sold in the ...
(Date:8/12/2015)... Aug. 12, 2015  New research unveiled at ... Android phones to steal users, fingerprints. Information released ... of fingerprint scanners on mobile devices, making the ... secure biometrics on mobile devices, HYPR Corp. recently ... convenient authentication systems with strong cryptographic security. More ...
(Date:8/11/2015)... -- Today, ZUK announced its Android smartphone Z1, featuring ... revenues in 2015 that relate to sales of FPC1155 for this ... 2,200 MSEK for 2015. Jörgen Lantto, CEO of FPC, ... smartphone manufacturer in China and we ... 155 for Z1 , ...
Breaking Biology News(10 mins):MedNet Solutions Experiences Explosive Corporate Growth 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2
(Date:8/27/2015)... GlassesOff (OTCBB: GLSO), a visual neuroscience technology company ... system, announced today a partnership with eight-time All-Star, ... to develop a new mobile app designed for professional and ... performance. Vision is the inception of every move ... or blocking a pass. The critical impact vision speed has ...
(Date:8/26/2015)... ... August 26, 2015 , ... MediVet Biologics, a leader in ... is to open in Manhattan, Kansas in early October, 2015. The location of ... research and development through collaboration with researchers from Kansas State University’s College of ...
(Date:8/26/2015)... , Aug. 26, 2015  Platform therapeutic company ... has received a $1.5M Phase II SBIR grant ... further develop its therapeutic agent to reduce arteriovenous ... in end stage renal disease (ESRD) patients undergoing ... Institute of Diabetes and Digestive and Kidney Diseases ...
(Date:8/26/2015)... 26, 2015 Despite recent ... the optimism in biotech,s forecast is the recent ... sciences advancements.  Active biotechnology & healthcare companies with ... (OTCQB: PBIO), Sequenom, Inc. (NASDAQ: SQNM ), ... Pharmaceutical Corp. (NASDAQ: RPTP ) and EnteroMedics ...
Breaking Biology Technology:Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 2Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 3MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 2New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 4New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 5New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 6New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 7
Cached News: